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Microbial coinfections have been associated with transient bursts of human immunodeficiency virus (HIV) viremia in
patients. In this study we investigated whether human T-cell leukemia virus type I (HTLV-I), another human retrovirus that is
prevalent among certain HIV-infected populations, can induce HIV-1 replication in patients who had been successfully treated
with highly active antiretroviral therapy. We demonstrate that supernatants from HTLV-I-producing MT-2 cells can induce in
vitro replication of HIV-1 from highly purified, resting CD41 T cells obtained from individuals with undetectable plasma
viremia. Depletion of proinflammatory cytokines from the supernatants reduced, but did not abrogate, the ability to induce
HIV-1 replication, indicating that other factors such as HTLV-I Tax or Env also have a role. The HTLV-I-mediated effect does
not require productive infection: exposure to heat-inactivated HTLV-I virions, purified Tax protein, or HTLV-I Env glycoprotein
also induced expression of HIV-1. Furthermore, we demonstrate that coculture of resting CD41 T cells with autologous CD81
T cells markedly inhibits the HTLV-I-induced virus replication. Our results suggest that coinfection with HTLV-I may induce
viral replication in the latent viral reservoirs; however, CD81 T cells may play an important role in controlling the spread of
virus upon microbial stimulation. © 2000 Academic Press
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In HIV-infected patients who are receiving highly ac-
tive antiretroviral therapy (HAART), plasma viremia often
becomes undetectable; however, a small reservoir of
latently infected, resting CD41 T cells has been shown to
persist for considerable periods of time (Finzi et al., 1997;
ong et al., 1997; Chun et al., 1997a). This latent reser-
oir of HIV resides predominantly in the lymphoid tissue
Chun et al., 1997b), a microenvironment where a variety
f immune responses are mounted. Since microbial coin-
ections evoke potent immune responses and are often
ssociated with transient bursts of HIV viremia (reviewed
y Blanchard et al., 1998; Wahl and Orenstein, 1997), it is
ikely that stimulation of the latent reservoir of HIV with
icrobial coinfections induces reactivation of HIV.
Several laboratory and epidemiological studies sug-
ested that HTLV-I infection accelerates the clinical pro-
ression of HIV disease in coinfected individuals (Bar-
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514holomew et al., 1987; Cleghorn and Blattner, 1992; Fantry
t al., 1995; Gotuzzo et al., 1992; Page et al., 1990; Pag-
iuca and Mufti, 1990; Schechter et al., 1994), although
ot all studies have confirmed these observations (Har-
ison et al., 1997). We recently demonstrated in several
ifferent systems that HTLV-I-infected cells mediate sol-
ble activity that is capable of enhancing HIV-1 replica-
ion in adjacent CD41 T cells in a paracrine manner
Moriuchi et al., 1998a). Since it is generally considered
hat coinfection of HTLV-I and HIV-1 in the same cell
arely occurs in vivo, such paracrine activity may be
hysiologically relevant to the above-noted clinical ob-
ervations.
In this study we investigated whether HTLV-I infection
s able to induce reactivation of HIV-1 from latently in-
ected reservoirs. To do so, we isolated highly purified,
esting CD41 T cells from HIV-infected individuals,
hose plasma virus loads were undetectable, and stim-
lated them with HTLV-I-infected cell-derived soluble
actors. We demonstrate that HTLV-I-infected cell-derived
oluble factors induce replication of HIV-1, and that the
TLV-I-mediated effect does not require productive in-
ection with HTLV-I. Exposure to heat-inactivated HTLV-I
irions, purified Tax protein, or HTLV-I Env glycoprotein
lso induced expression of HIV-1 from these cells. The
TLV-I-mediated effect was partly, but not entirely, de-
endent on the induction of proinflammatory cytokine
roduction. Thus, it is reasonable to assume that HTLV-I
oinfection actually induces reactivation of HIV in latently
nfected reservoirs in vivo. This study also demonstrates
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515HTLV-I INDUCES HIV-1 REPLICATIONthat CD81 T cells efficiently block the spread of virus in
his setting, implying their critical role in controlling latent
IV-1 infection in vivo.
RESULTS
ellular activation in resting CD41 T cells upon
timulation with HTLV-I-infected cell-derived factors
First, we investigated whether HTLV-I-infected cell-
erived factor(s) are able to activate highly purified, rest-
ng CD41 T cells derived from HIV-infected individuals,
whose levels of plasma virus loads were below detect-
ability by the assays used (Table 1). These cells ex-
pressed no detectable HLA-DR (,0.1%) or CD69 (,0.1%)
on their cell surfaces (Table 1; data not shown); 3H
incorporation into these cells was indistinguishable from
that of background levels (data not shown). Therefore,
although we cannot rule out a possibility that very small
percentages of activated T cells were left, the majority of
those cells represent resting CD41 T cells. These cells
ere either unstimulated or stimulated with crude super-
atants from HTLV-I-infected cell cultures or PHA. The
rude supernatant from MT-2 cells contained copious
mounts of proinflammatory cytokines as well as HTLV-I
irions and soluble Tax protein (Moriuchi et al., 1998a).
timulation with crude supernatants from MT-2 cell cul-
ures variably induced expression of HLA-DR (data not
hown) and CD69 (Table 1) on the surface of resting
D41 T cells and increased 3H incorporation into these
ells (data not shown).
nduction of HIV-1 replication from resting CD41 T
ells by stimulation with HTLV-I-infected cell-derived
actors
Since crude supernatants from HTLV-I-infected cell
ultures potently activated resting CD41 T cells, we next
investigated the ability of these supernatants to induce
T
Profiles of HIV
Patient
CD41 T cells
(cells/ml)
Plasma HIV RNAa
(copies/ml)
1 406 ,500 AZ
2 899 ,500 AZ
3 1023 ,50 D4
4 284 ,500 De
5 303 ,50 AZ
a Plasma HIV RNA was measured by bDNA assays (Chiron) in patie
ssay, Roche Molecular Diagnostic Systems) in patients 3 and 5.
b AZT, zidovudine; 3TC, lamivudine; D4T, stavudine; ddI, didanosine.
c nd, not done.replication-competent HIV-1 in these cells in vitro. Stim-
ulation with HTLV-I-infected cell culture supernatantsinduced p24 production in highly purified, resting CD41 T
cells from all five patients tested, while p24 Ag was not
detected in unstimulated CD41 T cells or CD41 T cells
ncubated with supernatants from control cells (i.e., A3.01
D41 T-cell line) (Table 2). HIV-1 isolated from all five
patients was replication-competent and was able to fur-
ther replicate in PHA/IL-2-stimulated PBMC derived from
uninfected healthy donors (data not shown).
Both viral and host factors induce HIV-1 replication
upon HTLV-I infection
HTLV-I-infected cell-derived factors include viral fac-
tors that exist extracellularly (e.g., soluble Tax protein
and HTLV-I Env glycoprotein on the surface of virions or
infected cells) as well as host factors such as proinflam-
matory cytokines. Therefore, effects of each of these
factors on the induction of HIV-1 replication were also
tested in resting CD41 T cells obtained from patients 1
hrough 4 during their second visit. As shown in Table 3,
epletion of viral or cellular factors from supernatants
erived from MT-2 cells markedly reduced their ability to
nduce HIV replication in these cells (in cases of deple-
ion of Tax or proinflammatory cytokines in patient 1) or to
elow the threshold of the assay (in cases of depletion of
cted Patients
rapyb
CD69 (%)
Unstimulated MT-2 sup PHA
, Indinavir ,0.1 37.0 35.5
, Efavirenz ,0.1 21.8 30.3
, Indinavir ,0.1 21.4 ndc
e, Indinavir ,0.1 9.3 nd
Indinavir ,0.1 17.1 nd
, and 4, and by RT-PCR assays (Amplicor Ultrasensitive HIV-1 Monitor
TABLE 2
Induction of HIV-1 Replication by Soluble Factors Derived from
HTLV-I-Infected Cells
Patient
p24 (pg/ml)
Unstimulated A3.01 sup MT-2 sup PHA
1 ,7.8 ,7.8 42.0 32.2
2 ,7.8 ,7.8 524.0 120.0
3 ,7.8 ,7.8 78.2 86.4
4 ,7.8 ,7.8 10.5 nda
5 ,7.8 ,7.8 21.6 ndABLE 1
-1-Infe
The
T, 3TC
T, 3TC
T, 3TC
lavirdin
T, ddI,
nts 1, 2a nd, not done.
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516 MORIUCHI AND MORIUCHIHTLV-I virions in patient 1 and depletion of any of these
factors in patient 4). In another set of experiments, either
heat-inactivated HTLV-I virions or purified Tax protein
could induce replication of HIV-1 (Table 4). Furthermore,
cocultures with BSC-1 cells expressing HTLV-I Env gly-
coprotein induced HIV-1 replication in these cells, al-
though those with control BSC-1 cells did not (Table 4).
HIV-1 induced by these factors was replication-compe-
tent and was able to further replicate in PHA/IL-2-stim-
ulated PBMC derived from uninfected healthy donors
(data not shown). Taken together, these data indicate
that induction of HIV-1 replication in resting CD41 T cells
ay be inducible by both viral and host factors derived
rom HTLV-I-infected cells.
D81 T cells inhibit induction and/or spread of HIV-1
eplication in latently infected, resting CD41 T cells
pon microbial stimulation
CD81 T cells have been shown to inhibit HIV-1 repli-
cation in either a cytolytic or noncytolytic manner (re-
viewed by Levy et al., 1996). A recent study clearly dem-
onstrated that CD81 T cells play a critical role in control-
ing viremia during primary and chronic simian
mmunodeficiency virus infection in vivo (Schmitz et al.,
999). To investigate whether CD81 T cells play an in-
ibitory role in the induction and/or spread of HIV-1
TABLE 3
Effects of HTLV-I-Infected Cell-Derived Factors on the Induction
of HIV-1 Replication
Stimulation
p24 (pg/ml)
Patient 1 Patient 4
No stimulation ,7.8 ,7.8
HTLV-I-infected cell sup
(Crude) 98.2 11.8
(Tax-depleted) 10.0 ,7.8
(HTLV-I virion-depleted) ,7.8 ,7.8
(TNF/IL-1/IL-6-depleted) 20.4 ,7.8
TABLE 4
Effects of HTLV-I-Derived Factors on the Induction
of HIV-1 Replication
Stimulation
p24 (pg/ml)
Patient 2 Patient 3
No stimulation ,7.8 ,7.8
Heat-inactivated HTLV-I virions 15.7 26.2
GST ,7.8 ,7.8
GST-Tax 50.8 9.6
Coculture with BSC-1 cells
(vWT-infected) ,7.8 ,7.8
(vWR-env17-infected) 43.0 26.9eplication in resting CD41 T cells upon microbial stim-
lation, autologous CD81 T cells were cocultured with
urified resting CD41 T cells that had been stimulated
ith HTLV-I-infected cell supernatants. HIV-1 replication
as markedly delayed and suppressed (Fig. 1) or unde-
ectable (data not shown) in CD41 T-cell/CD81 T-cell
cocultures compared to results in CD41 T-cell cultures.
hese results suggest that CD81 T cells play a critical
ole in inhibiting the induction and/or spread of HIV-1
eplication in latent reservoirs in vivo upon stimulation
with microbes such as HTLV-I.
DISCUSSION
Interaction between HIV and other microbial patho-
gens has been the subject of extensive investigation.
Coinfection with certain microbial pathogens including
HTLV-I, as examined in the present study, has been
associated with transient bursts of HIV viremia or pro-
gression of HIV disease (reviewed by Blanchard et al.,
1998; Wahl and Orenstein, 1997). However, it has been
FIG. 1. CD81 T cells inhibit induction and/or spread of HIV-1 in
atently infected, resting CD41 T cells upon microbial stimulation.
Resting CD41 T cells were isolated from HIV-infected individuals,
incubated alone or cocultured with autologous CD81 T cells at a ratio
of 4:1 on Day 0, and were left either unstimulated or stimulated with
HTLV-I-infected MT-2 cell supernatants. Cell-free supernatants were
collected every 3 days after stimulation for p24 assays. Similar results
were obtained for three other donors.unclear what effect these coinfections have on latent
reservoirs of HIV-1. The present study demonstrates that
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517HTLV-I INDUCES HIV-1 REPLICATIONHTLV-I-infected cell-derived factors can induce in vitro
replication of HIV in highly purified, resting CD41 T cells
erived from HIV-infected individuals with undetectable
lasma viremia.
Coinfection of the same cell with HIV and other micro-
ial pathogen(s) is probably rare in vivo, considering the
act that very few cells harbor HIV-1 (Bertram et al., 1996);
herefore, direct interaction between two different patho-
ens is unlikely to occur in vivo. In contrast, soluble
actors secreted by microbially infected cells can medi-
te their effects on neighboring cells in a paracrine
anner. A previous study from this laboratory showed
hat a combination of proinflammatory cytokines can
nduce in vitro replication of HIV-1 from highly purified,
esting CD41 T cells (Chun et al., 1998). In this study, we
demonstrated that the ability of supernatants derived
from HTLV-I-infected cells to induce replication of HIV is
reduced, but not totally abrogated, when proinflamma-
tory cytokines are depleted. Recently we demonstrated
that soluble factors derived from macrophages stimu-
lated with bacterial cell-wall components have effects
similar to those factors derived from HTLV-I-infected
cells and are capable of inducing HIV-1 replication in
latently infected, resting CD41 T cells (Moriuchi et al.,
2000). These results suggest that reactivation of HIV-1
from the latent reservoir may be induced by a wide array
of microbial pathogens through cytokine networks.
The present study also demonstrated that viral factors
(i.e., HTLV-I Tax protein and Env glycoprotein), by them-
selves, also play a role in the induction of HIV replication.
In this regard, we previously demonstrated that Tax pro-
tein can induce the expression of HIV-1 coreceptors
(Moriuchi et al., 1998a, 1999). The HTLV-I-mediated effect
is not totally dependent on its ability to induce proinflam-
matory cytokine production, since subtraction of these
cytokines from the supernatants did not completely ab-
rogate HTLV-I induction of HIV expression. Whether the
two viral factors (Tax and Env) act independently or
synergistically remains unknown. While experimental re-
sults presented in Table 3 showed that depletion of
either factor abrogated the ability of the supernatant to
induce HIV-1 replication, experimental results shown in
Table 4 suggested that Tax or Env alone was sufficient
for the induction of HIV-1. By using PBMC obtained from
HIV-uninfected individuals that had been infected with a
replication-incompetent, luciferase-reporter molecular
clone (NL4–3luc-R2E2), we demonstrated that Tax or Env
could induce HIV-1 expression in a dose-dependent
manner, and that a combination of suboptimal doses of
the two factors could induce HIV-1 expression (data not
shown). Thus, these results suggest that the actions of
Tax and Env are independent and additive, and that both
factors are required when each of them was suboptimal
by itself. In a similar assay HTLV-I Env-mediated effects
were markedly reduced by neutralization with anti-HTLV-I antiserum (data not shown), indicating the spec-
ificity of these effects.
We also demonstrated that exposure to HTLV-I Env
glycoprotein appears to be sufficient to induce HIV rep-
lication from resting CD41 T cells. A number of viral
glycoproteins have been implicated to function in the
transduction of signals to cells via ligand-receptor-like
interactions (Davis et al., 1997; Karp et al., 1996; Sugano
t al., 1997; Weissman et al., 1997; Yurochko et al., 1997;
Roberge et al., 1996). It was previously reported that
HTLV-I virions can stimulate lymphocytes like a mitogen
(Zack et al., 1988). Therefore, although a cellular recep-
tor(s) for HTLV-I has not as yet been convincingly dem-
onstrated, it is possible that HTLV-I attachment to cells
via Env glycoprotein triggers a signaling pathway(s) that
leads to transcriptional activation of the HIV-1 LTR. We
are currently investigating the molecular mechanisms of
the HTLV-I Env-mediated effect.
The present study also suggests that CD81 T cells
ay play a role in controlling latent HIV infection. Despite
he fact that CD81 T cells were previously shown to
suppress HIV infection by either cytolytic or noncytolytic
mechanisms (reviewed by Levy et al., 1996), it is unclear
whether these cells are critical for the prevention of
reactivation of HIV. Data from this study indicate that
coculture of latently infected, resting CD41 T cells with
CD81 T cells can markedly suppress productive HIV
nfection in these cells upon microbial stimulation. Al-
hough our experiments do not delineate whether CD81
T cells directly block expression of virus from the reac-
tivated cells in the latent reservoir or whether they inhibit
the spread of virus to other cells following reactivation,
the physiological significance of this finding warrants
further investigation.
In conclusion, this study demonstrated that microbial
coinfections such as HTLV-I infection may have an im-
pact on the induction of HIV replication, even in patients
who have been successfully treated with HAART, and
may have implications in the management of these pa-
tients.
MATERIALS AND METHODS
Patient population
Five HIV-1-infected patients who were receiving
HAART were subjected to pheresis to obtain peripheral
blood mononuclear cells (PBMCs) according to proto-
cols approved by the National Institute of Allergy and
Infectious Diseases Institutional Review Board. All pa-
tients were free of symptoms related to HIV or other
microbial infections, and plasma HIV RNA was undetec-
ted by branched (b) DNA assays (Chiron, Berkeley, CA) or
RT-PCR assays (Amplicor Ultrasensitive HIV-1 Monitor
assay; Roche Molecular Diagnostic Systems, Alameda,
CA) in these patients (Table 1).
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518 MORIUCHI AND MORIUCHICells and reagents
HTLV-I-transformed MT-2 cells were propagated as
described previously (Moriuchi et al., 1998a). Crude su-
pernatants from MT-2 cells were clarified by low-speed
centrifugation and filtered through 0.45-mm filters to re-
ove cells. The supernatants were not toxic to resting
D41 T-cell cultures at the concentration used (data not
shown). Where indicated, the supernatant was treated
with either a cocktail of antibodies to TNF-a, IL-1b, and
IL-6 (R&D Systems, Minneapolis, MN), and anti-Tax an-
tiserum or control rabbit serum, followed by protein A/G
Sepharose (Pierce, Rockford, IL), and immune com-
plexes bound on the Sepharose were removed by exten-
sive washing, as described previously (Moriuchi et al.,
1998a). HTLV-I virions were removed by ultracentrifuga-
tion. Concentrations of cytokines in these supernatants
were measured by commercially available ELISA kits
(R&D Systems).
Purified HTLV-I virions (purchased from Advanced Bio-
technologies, Columbia, MD) were derived from MT-2
cells, devoid of any other MT-2 cell-derived soluble fac-
tors, and were incubated at 56°C for 1 h to abrogate
infectivity. Glutathione-S-transferase (GST) and GST-Tax
fusion protein were prepared as described previously
(Moriuchi et al., 1998a). Recombinant vaccinia virus ex-
pressing HTLV-I Env glycoprotein (designated as vWR-
env17) was a generous gift of H. Shida (Kyoto University,
Japan) (Shida et al., 1987). BSC-1 cells were infected with
either vWT (wild type vaccinia virus) or vWR-env17 at a
multiplicity of infection of 10 for 12 h at 33°C (Moriuchi et
al., 1997), treated with mitomycin C to inhibit cell prolif-
eration and replication of vaccinia virus, and mixed with
resting CD41 T cells (see below) at a ratio of 1:5.
Anti-HTLV-I antisera, derived from asymptomatic
TLV-I carriers, were kindly provided by the Red Cross
lood Center in Nagasaki prefecture, Japan.
timulation of resting CD41 T cells
Resting CD41 T cells and CD81 T cells were isolated
from PBMCs as described previously (Chun et al., 1998;
Moriuchi et al., 1996). Purities of resting CD41 T cells and
D81 T cells were .99 and .98%, respectively. Approx-
mately 10 3 106 resting CD41 T cells derived from
IV-1-infected patients were incubated alone or along
ith 2.5 3 106 autologous CD81 T cells with either
omplete medium (RPMI 1640 supplemented with 10%
CS), 50% MT-2 cell supernatants in complete medium,
r complete medium with PHA (3 mg/ml; Sigma Chemi-
cal, St. Louis, MO). Where indicated, the resting cells
were stimulated with either 200 ng of GST or GST-Tax
protein or 50 ng of heat-inactivated HTLV-I virions, or
were cocultured with BSC-1 cells that had been infected
with either vWT or vWR-env17, followed by mitomycin C
treatment (see above). Cultures were maintained in a
37°C CO2 incubator for 16 days, and supernatants fromeach culture were collected every 4 days during the
incubation period for determination of HIV-1 p24 by
ELISA (Coulter, Miami, FL).
Flow cytometric analysis and [3H]thymidine
incorporation
To determine the levels of cellular activation of latently
infected, resting CD41 T cells after stimulation with MT-2
cell supernatants, flow cytometric analyses of cellular
activation markers were performed using the following
antibodies: FITC-conjugated anti-CD69, FITC-conjugated
anti-CD25, or FITC-conjugated anti-HLA-DR antibodies
(Becton Dickinson Immunocytometry) along with PE-con-
jugated anti-CD4 (Becton Dickinson Immunocytometry
Systems, San Jose, CA) 4 days after incubation. [3H]Thy-
midine incorporation was also determined for 104 cells 4
ays after incubation.
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